Search the Newsreel

Advani Hotels & Resorts (India) standalone net profit declines 40.85% in the June 2026 quarter

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal

Vivani Medical (NASDAQ: VANI) announced full enrollment in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also signed a non-exclusive agreement with Novo Nordisk for evaluating NPM-139 and its NanoPortal technology. Additionally, Vivani …

KIRAC GALVANIZ (TCKRC) Hisse Senedi

Univest Financial Director Michael L. Turner Sells 8,000 Shares at $43.04 Average Price

Univest Financial Director Michael L. Turner sold 8,000 shares of the company's common stock on August 13, 2026, at a weighted average price of $43.035 per share. The transaction was detailed in a Form 4 filed with the SEC on August 14, 2026. Following …

Advani Hotels Q1FY27: ఆదాయం పెరిగినా, ఖర్చులు పెరిగి లాభం డౌన్!

Michael Turner Sells 8,000 Shares of Univest Corporation of Pennsylvania (NASDAQ:UVSP) Stock

Director Michael Turner sold 8,000 shares of Univest Corporation of Pennsylvania (NASDAQ:UVSP) stock for $344,240, reducing his direct holdings by nearly 25%. Following the sale, UVSP shares rose 0.4% to $43.15, despite the company reporting quarterly EPS below consensus estimates, though revenue exceeded expectations. …

Univest Financial (UVSP) director sells 8,000 shares in August trade

Michael L. Turner, a director at Univest Financial Corp (UVSP), sold 8,000 shares of common stock on August 13, 2026, at a weighted average price of $43.035 per share. The sale occurred in multiple transactions within a price range of $42.9386 to $43.2336. Following …

TCKRC Hisse Yorumları (KIRAC GALVANIZ Güncel Yorumlar)

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI) reported a quarterly loss of $0.07 per share, exceeding analyst estimates by $0.01. Despite beating expectations, shares fell 2.2% to $1.34. The company has an average "Hold" rating from analysts with a target price of $3.75, and director Gregg Williams recently …

Vivani Medical: Q2 Earnings Snapshot

Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027

Vivani Medical (VANI) has reported a net loss of $6.4 million for Q2 2026 and $13.2 million for the first half of 2026, with cash and equivalents totaling $19.9 million, which is projected to fund operations into Q2 2027. The company is advancing its …

Form 8K Vivani Medical Inc For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 13th, as tracked by Investing.com. The brief mention indicates a financial disclosure event for the company, with the stock symbol VANI noted to have experienced a -2.19% change.

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …

20 Participants Dosed in Semaglutide Trial; Data Due in November

Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …

UNIVEST FINANCIAL Corp SEC Filing (Aug 13, 2026)

This article reports an SEC Form 144 filing by UNIVEST FINANCIAL Corp (UVSP) on August 13, 2026. The filing details the proposed sale of 8,000 shares of common stock with an aggregate market value of $340,000 by an individual, acquired in 2010 through a …

Assenagon Asset Management S.A. Acquires 100,780 Shares of Univest Corporation of Pennsylvania $UVSP

Assenagon Asset Management S.A. significantly increased its stake in Univest Corporation of Pennsylvania (NASDAQ:UVSP) by 39.2%, purchasing an additional 100,780 shares to bring its total holdings to 358,183 shares valued at approximately $15.7 million. This move coincides with an improved analyst sentiment, with Zacks …

Univest Financial (NASDAQ: UVSP) files Form 13F showing $2.04B across 478 positions

Univest Financial Corp (NASDAQ: UVSP) has filed a quarterly Form 13F-HR, disclosing equity and related securities holdings totaling $2.04 billion across 478 positions as of June 30, 2026. The report includes holdings managed by Univest Bank & Trust Co. and GIRARD ADVISORY SERVICES, LLC. …

Univest Financial Corp (UVSP) Stock News Today

This page provides current stock information for Univest Financial Corp (UVSP), including its market cap, P/E ratio, and recent stock price movements. It indicates that more news regarding the company's earnings, analyst ratings, and key developments will be available soon. The page serves as …

Univest Financial Corp (UVSP) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Univest Financial Corp (UVSP), noting its current earnings forecast score is 6.00 and ranks 286 out of 394 in the Banking Services industry. Analysts have set an average price target of $34.00 for UVSP, with expectations for …

Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial

Vivani Medical announced the completion of enrollment and initial dosing for all 20 participants in its Phase 1 SLIM-1 trial. The trial is evaluating NPM-139, a long-acting semaglutide implant, for chronic weight management, focusing on its safety and tolerability.

Vivani Medical, Inc. (VANI) stock price, news, quote and history

Vivani Medical, Inc. (VANI) is a clinical-stage biopharmaceutical company focused on developing miniaturized subdermal drug implants for chronic diseases. The article provides a comprehensive overview of VANI's stock performance, including its current price, historical data, key financial metrics, and analyst ratings. It also details …

FMR LLC (UVSP) discloses 5.6% Univest Financial stake in Schedule 13G/A

FMR LLC has filed an amended Schedule 13G, disclosing a 5.6% beneficial ownership stake in Univest Financial Corp (UVSP) common stock, totaling 1,570,524.63 shares. FMR LLC holds sole dispositive power over these shares and sole voting power over 1,570,397.00 shares, with no shared voting …

Semaglutide implant trial doses all 20 participants; data expected in November

Vivani Medical announced the successful dosing of all 20 participants in its SLIM-1 Phase 1 trial for NPM-139, a miniature, subdermal semaglutide implant designed for chronic weight management. The trial compares low-dose NPM-139 with Wegovy and focuses on safety, tolerability, pharmacokinetics, and weight change. …

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Vivani Medical announced the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a miniature, subdermal semaglutide implant for chronic weight management. The trial involves 20 GLP-1 naïve participants in Australia and aims to assess the safety, tolerability, and pharmacokinetics …

Vivani Medical (VANI) to Announce Earnings on Wednesday

Vivani Medical (VANI) is set to release its Q2 2026 earnings before market open on Wednesday, August 12th, with analysts expecting a loss of $0.08 per share. The company previously matched consensus estimates with a similar loss in Q1. Insider transactions show Director Gregg …

Univest Corporation of Pennsylvania $UVSP Shares Bought by Sei Investments Co.

UVSP5500518 Bond Profile — Key Metrics

This article provides key metrics for the Univest Financial Corporation 7.25% bond, CUSIP UVSP5500518, maturing on November 15, 2032. It details the bond's issue and maturity dates, outstanding amount, face value, and coupon rate. The profile also includes a description of Univest Financial Corp. …

Enterprise value to EBITDA forward of Vivani Medical, Inc. – NASDAQ:VANI

This page from TradingView displays the "Enterprise value to EBITDA forward" metric for Vivani Medical, Inc. (NASDAQ:VANI). It indicates that the market was closed with no trades at the time of viewing. The content is primarily a financial data point for the company.

Vivani Medical (VANI) awards CEO 200K stock options and 100K RSUs

Vivani Medical, Inc. (VANI) granted its CEO, Adam Mendelsohn, 200,000 stock options and 100,000 performance-based Restricted Stock Units (RSUs) on July 28, 2026. The stock options have a $1.31 exercise price and vest over four years, while the RSUs vest in three stages based …

Univest Financial rated BUY on strong loan growth and record income despite sector discount.

Univest Financial Corp. received a BUY rating due to its record net interest income and robust commercial loan growth. Despite trading at a discount compared to its sector peers, the company projects 14% forward EPS growth and offers a 2% dividend yield along with …

Vivani Medical Inc (VANI) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Vivani Medical Inc (VANI) by TradingKey. The company currently has a financial score of 5.69, ranking 193 out of 199 in the Healthcare Equipment & Supplies industry, indicating robust financial status but low operating efficiency. The …

Sylvania Platinum (SLP) Achieves Record FY2026 4E PGM Production of 95,885 Ounces Amid Revenue Decline

Form 4 Vivani Medical Inc For: 30 July By Investing.com

This article reports on a Form 4 filing for Vivani Medical Inc., dated July 30th. Form 4 filings are regulatory documents that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of company …